AC Milan are closing a deal for Partizan Belgrade prospect Andrej Kostic. The 19 year-old is a regular with Partizan and set to move to Milan this summer, reports transfer expert Fabrizio Romano.

ISLAMABAD: The Oil and Gas Regulatory Authority (Ogra) and Pakistan State Oil (PSO) on Monday came under fire for insufficient and lethargic online integration and automation of stock and supply ...

The management of Pakistan State Oil (PSO), the country’s largest OMC, has approved the appointment of Abdus Sami as chief executive officer (CEO) on an interim basis. The listed company shared the ...

Milan, it’s now official: the talented Andrej Kostic is joining from Partizan Belgrade. Milan are looking to the future in search of young talent to bring into the second team, coached by Massimo Oddo ...

The former Real Madrid and Fiorentina player has launched a scathing attack regarding the Montenegrin star’s imminent move to the Rossoneri Another ‘André’ situation for Milan? Probably not, as the ...

PSO says there have been six power outages between November and December. The electric company says power outages have lasted from a few minutes to just under five hours. “We understand that it’s not ...

AC Milan have completed the signing of Partizan Belgrade striker Andrej Kostic. The Montenegro international will join Milan on July 1, 2026. Kostic, 19, will initially be registered with Milan Futuro ...

New Supreme Leader of Iran, Ayatollah Mojtaba Khamenei, does not exercise the same centralized authority as his late father, Ali Khamenei; instead, power is shifting toward senior command of Islamic ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

PSO is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of PSO shares has held flat since the market last closed. This is a 0.00% change.

Pearson plc is leveraging AI-driven efficiency and digital transformation to drive sustained margin expansion and free cash flow growth. PSO's adjusted operating profit grew 6% in FY 2025, outpacing 4 ...

Melinda Gooderham, MD, MSc, FRCPC, discusses findings from the Latitude PsO 3001 and Latitude PsO 3002 studies evaluating zasocitinib. Zasocitinib, a highly selective tyrosine kinase 2 (TYK2) ...